Amorfix has Alzheimer’s disease blood screening breakthrough
May 4, 2010 by stephenkilmer · Leave a Comment
Amorfix Life Sciences (TSX:AMF) has detected Alzheimer’s disease-associated aggregated Beta-amyloid (ABeta), the hallmark of the disease, in the blood of transgenic mice, including both oligomeric and fibrillar aggregates of ABeta, which are generally considered to be the toxic forms and major contributors to brain dysfunction in AD. “This milestone achievement represents the first time that [...]
Listen to BioTuesdays 
